Skip to content

Symptom Management Program for Hemodialysis Patients

Symptom Management Program for Hemodialysis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01620580
Enrollment
60
Registered
2012-06-15
Start date
2011-09-30
Completion date
2012-05-31
Last updated
2012-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemodialysis-induced Symptom

Keywords

sleep disturbance, tiredness, itching & numbness

Brief summary

Self-management intervention may decrease symptom burden and improve functioning over time.

Detailed description

Self-management intervention (strategies) may decrease symptom burden (sleep disturbance, tiredness; itching and numbness) and improve functioning (social, physical and emotional) over time(baseline, 3 weeks and 8 weeks).

Interventions

BEHAVIORALSelf-management

Participants in the intervention group will receive printed self management strategies each of the 5 symptoms, a symptom diary with the self-management strategies and a 15 minutes discussion. The intervention script will instruct participants on how to use the printed strategies by PI and RA #1. Week 3

The control or usual care group will receive a symptom diary designed for the control group without any strategies and a 5 minutes discussion on how to complete the diary from RA# 1. The PI will make weekly follow up calls on the same schedule as the intervention group starting week 4 until week 7 for a total of 4 calls focusing on enhancing healthy eating skills & adherence to renal diet and fluid restriction without discussing any intervention with the group.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. age ≥ 18 years old, 2. on HD three times a week, 3. received HD for ≥ six months, 4. read and write English, 5. have telephone service.

Exclusion criteria

* history of dementia, * acquired immunodeficiency syndrome (AIDS) and active cancer, and * inability to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Decrease symptom burden8 weeksThe study aims are: 1\. To compare the differences between the self management intervention and control group on the following outcomes: 1. Decreased symptoms: itching, tiredness, numbness, sleep disturbance (difficulty falling asleep & difficulty staying asleep); 2. Adherence to treatment diary Improved social functioning, physical functioning and emotional status.

Secondary

MeasureTime frameDescription
Feasibility of implementing self management intervention5 weeksTo evaluate the feasibility of implementing the self management intervention for a larger randomized controlled studyTreatment delivered (number of interventions sessions delivered and strategies used); Treatment receipts (understanding of strategies); and Treatment enactment (reported perception of usefulness of the strategies).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026